• Blood Centrifugation

    Sunstein prosecuted blood centrifugation patents for Haemonetics Corporation, a leader in the field of blood processing. The patented technologies allow blood components to be collected and processed for life-saving transfusions.

  • Purification

    Innovations by DEKA Research increase the efficiency of water purification systems, while reducing power and maintenance requirements. International patent applications like the one Sunstein prepared for DEKA can lead to worldwide adoption of a useful technology – one that can supply the developing world with access to safe water.

  • Shaft/hub

    Custom Machine & Tool Co. invented a novel shaft/hub connection device for precise component positioning and tight run-out control in demanding torque transmission applications such as timing-belt pulleys. Rigorous engineering analyses, as shown, demonstrate the benefits of CMT’s invention compared to other connection systems. The patent Sunstein obtained bolsters CMT’s position in a crowded marketplace.

  • Intravascular Stent

    Sunstein prosecuted a patent for a new stent that retains high radial strength but is more flexible and easier to insert into a patient’s coronary artery. The Crown™ stent is the product of our client DEKA’s collaboration with Cordis Corp., a Johnson & Johnson company, to improve the design of the Palmaz-Schatz® stent, the first intravascular stent proven to reduce blockage in arteries.

Patents. Juries. Success.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

Abbott Laboratories v Syntron Bioresearch, Inc.

In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories.

Our successful advocacy extends to patent reexaminations and interferences.

Winning at Post Grant Proceedings

Samsung Electronics Co., Ltd. v. Arendi S.A.R.L.

Samsung attacked our client’s patent in the Patent Trial and Appeal Board (PTAB) on grounds of obviousness. We persuaded the PTAB that an element of the claims was not disclosed by the cited references and thus prevented the inter partes review from even being instituted.

Click here for our Inter Partes Review flowchart, which shows a comprehensive timeline of deadlines and steps in an IPR proceeding.

Spotlight on Patents

diagram1 For our client Dr. Leslie Stern of Fall River, Massachusetts, we recently obtained US Patent No. 8,460,310, describing a medical device for use in minimally invasive spine surgery.

In the News

Our Latest Thinking

  • US companies doing business in Europe must navigate between the EU’s reverence for data privacy and the US’s emphasis on law enforcement. The regulatory situation is now chaotic.

    More...
  • Patent owners often ask the International Trade Commission to bar the importation of infringing goods. Recent court decisions both expand and contract the ITC’s jurisdiction.

    More...
  • The Google Books project continues to push the boundaries of fair use. The Second Circuit is the latest court to examine the elasticity of that doctrine.

    More...

Free Subscription

See more in Publications/News